Romark IVA - Digital PDF interaction 10.13
ALINIA ® Dosing14ALINIA Tablets dosing and administrationFor patients 12 years and older:1 tablet (500 mg) po BID x 3 days with food+++ALINIA OS dosing and administrationFor patients 1 year and older:12dosetimes per dayAge Dosage Duration1-3 years5 mL of ALINIA for Oral Suspension (100 mg nitazoxanide) BID with food3day course of treatment -taken with food4-11 years≥12 years10 mL of ALINIA for Oral Suspension (200 mg nitazoxanide) BID with food25 mL of ALINIA for Oral Suspension (500 mg nitazoxanide) BID with food3 Days*IndicationsALINIA ® for Oral Suspension (patients 1 year of age and older) and ALINIA Tablets (patients 12 years and older)are indicated for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum.Limitations of Use: ALINIA for Oral Suspension and ALINIA Tablets have not been shown to be effective for thetreatment of diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients.Important Safety Information• ALINIA Tablets and ALINIA for Oral Suspension are contraindicated in patients with a prior hypersensitivityto nitazoxanide or any other ingredient in the formulations.
ALINIA ® Patient Savings15With the ALINIA co-pay program, your eligible commercially insured patients may payas little as $10 per prescription †• ALINIA is covered by most managed care plans• Your commercially insured patients can use the ALINIA co-pay card, or if they do not have one,an e-Voucher may be available• E-Vouchers are applied automatically for eligible patients at eVoucherRx TM pharmaciesVisit eVoucherRx.RelayHealth.com/storelookupto find a local participating storeMaximum benefit up to $300 for ALINIA Tablets †Maximum benefit up to $75 for ALINIA for Oral Suspension ††Terms and conditions apply. Get more information hereYou can also eScribe to one of ALINIA national pharmacypartners for fast and discreet home delivery:• Foundation Care Pharmacy: Earth City, MO (NCPDP Provider ID: 26355)• PantherRx: Pittsburgh, PA 15275 (NPI: 1316213531)*IndicationsALINIA ® for Oral Suspension (patients 1 year of age and older) and ALINIA Tablets (patients 12 years and older)are indicated for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum.Limitations of Use: ALINIA for Oral Suspension and ALINIA Tablets have not been shown to be effective for thetreatment of diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients.Important Safety Information• ALINIA Tablets and ALINIA for Oral Suspension are contraindicated in patients with a prior hypersensitivityto nitazoxanide or any other ingredient in the formulations.
- Page 1 and 2: When diarrhea persists more than 14
- Page 3 and 4: AGA Clinical Guidelines3In 2019 gui
- Page 5 and 6: About Giardiasis5In the U.S., Giard
- Page 7 and 8: ALINIA ® Tablets Clinical Study De
- Page 9 and 10: ALINIA ® Tablets Efficacy9ALINIA T
- Page 11 and 12: ALINIA ® OS Head-to-Head Data11ALI
- Page 13: ALINIA ® Safety Profile13Most Comm
ALINIA ® Dosing
14
ALINIA Tablets dosing and administration
For patients 12 years and older:
1 tablet (500 mg) po BID x 3 days with food
+
+
+
ALINIA OS dosing and administration
For patients 1 year and older:
1
2
dose
times per day
Age Dosage Duration
1-3 years
5 mL of ALINIA for Oral Suspension (100 mg nitazoxanide) BID with food
3
day course of treatment -
taken with food
4-11 years
≥12 years
10 mL of ALINIA for Oral Suspension (200 mg nitazoxanide) BID with food
25 mL of ALINIA for Oral Suspension (500 mg nitazoxanide) BID with food
3 Days
*Indications
ALINIA ® for Oral Suspension (patients 1 year of age and older) and ALINIA Tablets (patients 12 years and older)
are indicated for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum.
Limitations of Use: ALINIA for Oral Suspension and ALINIA Tablets have not been shown to be effective for the
treatment of diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients.
Important Safety Information
• ALINIA Tablets and ALINIA for Oral Suspension are contraindicated in patients with a prior hypersensitivity
to nitazoxanide or any other ingredient in the formulations.
Change language